Standard BioTools Inc (NASDAQ: LAB) is -14.48% lower on its value in year-to-date trading and has touched a low of $1.21 and a high of $3.04 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LAB stock was last observed hovering at around $1.89 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $1.89, the stock is -0.24% and -0.13% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.92 million and changing 0.00% at the moment leaves the stock -15.89% off its SMA200. LAB registered 16.67% gain for a year compared to 6-month loss of -31.77%. The firm has a 50-day simple moving average (SMA 50) of $1.8924 and a 200-day simple moving average (SMA200) of $2.24715.
The stock witnessed a -8.25% gain in the last 1 month and extending the period to 3 months gives it a -17.47%, and is 3.85% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.47% over the week and 5.49% over the month.
Standard BioTools Inc (LAB) has around 539 employees, a market worth around $701.47M and $136.30M in sales. Profit margin for the company is -120.81%. Distance from 52-week low is 56.20% and -37.83% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.48%).
The EPS is expected to grow by 56.74% this year.
Standard BioTools Inc (LAB) Top Institutional Holders
187.0 institutions hold shares in Standard BioTools Inc (LAB), with institutional investors hold 73.54% of the company’s shares. The shares outstanding are 371.15M, and float is at 359.12M with Short Float at 5.93%. Institutions hold 72.10% of the Float.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 63.96 million shares valued at $113.21 million. The investor’s holdings represent 17.1782% of the LAB Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 58.65 million shares valued at $103.81 million to account for 15.7524 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 21.75 million shares representing 5.8424% and valued at over $38.5 million, while VANGUARD GROUP INC holds 4.2981 of the shares totaling 16.0 million with a market value of $28.33 million.
Standard BioTools Inc (LAB) Insider Activity
#####
Standard BioTools Inc disclosed in a document filed with the SEC on Aug 27 ’24 that Casdin Partners Master Fund, L (Director) bought a total of 250,000 shares of the company’s common stock. The trade occurred on Aug 27 ’24 and was made at $2.19 per share for $0.55 million. Following the transaction, the insider now directly holds 54.03 million shares of the LAB stock.
Still, SEC filings show that on Aug 23 ’24, Casdin Partners Master Fund, L (Director) acquired 292,100 shares at an average price of $2.13 for $0.62 million. The insider now directly holds 53,625,821 shares of Standard BioTools Inc (LAB).
